MedPath

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
Private
Established
1884-01-01
Employees
10K
Market Cap
-
Website
http://www.mskcc.org

Quadrant High Dose Rate Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer: A Pilot Study

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Radiation: Intra Operative Radiation Therapy (IORT)
First Posted Date
2008-01-16
Last Posted Date
2015-12-22
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
51
Registration Number
NCT00595062
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

Phase 2
Completed
Conditions
CNS Lymphoma
CNS Brain Cancer
Non-Hodgkin's Lymphoma
Interventions
Other: Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
First Posted Date
2008-01-16
Last Posted Date
2024-04-01
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
33
Registration Number
NCT00596154
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Commack, Commack, New York, United States

Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma

Not Applicable
Completed
Conditions
Cervical Cancer
Endometrial Cancer
Cervical Carcinoma
Interventions
Other: Lymphatic Mapping
First Posted Date
2008-01-16
Last Posted Date
2011-09-08
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
151
Registration Number
NCT00595725
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma

Not Applicable
Completed
Conditions
SQUAMOUS CELL CARCINOMA
Interventions
First Posted Date
2008-01-16
Last Posted Date
2015-12-23
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
12
Registration Number
NCT00596219

Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Not Applicable
Completed
Conditions
Lymphoma
Interventions
Drug: Cytarabine, Leucovorin, Methotrexate, Procarbazine, Rituximab, Vincristine
First Posted Date
2008-01-16
Last Posted Date
2017-04-06
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
52
Registration Number
NCT00594815
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors

Phase 1
Completed
Conditions
Brain Tumor
Cns Cancer
Brain Cancer
Cognitive Dysfunction
Interventions
Other: donepezil and questionaires
First Posted Date
2008-01-16
Last Posted Date
2016-01-14
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
25
Registration Number
NCT00594633
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma

Not Applicable
Completed
Conditions
Primary Brain Tumor
Brain Cancer
Recurrent Malignant Gliomas
Interventions
Other: bevacizumab and radiation (IMRT)
First Posted Date
2008-01-16
Last Posted Date
2017-05-23
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
25
Registration Number
NCT00595322
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States

πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)

Phase 2
Completed
Conditions
Pediatric
Hodgkin's Disease
Interventions
Drug: COPP/ABV
Drug: intensive chemo with concurrent growth factor
First Posted Date
2008-01-11
Last Posted Date
2015-12-23
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
21
Registration Number
NCT00592111
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Model for Genetic Susceptibility: Melanoma

Active, not recruiting
Conditions
Melanoma
Skin Cancer
Interventions
Behavioral: Questionnaire
First Posted Date
2008-01-11
Last Posted Date
2024-08-02
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
4082
Registration Number
NCT00591500
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Randomized Clinical Trial Assessing Smoking Cessation Interventions In Dental Clinic Smokers

Active, not recruiting
Conditions
Smoking Cessation
Interventions
Behavioral: Standard Care only
Behavioral: Dental Hygienist provided counseling with personalized risk communication + Brief Questionnaire
Behavioral: Dental Hygienist provided counseling + Brief Questionnaire
First Posted Date
2008-01-11
Last Posted Date
2025-01-03
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Target Recruit Count
1072
Registration Number
NCT00591175
Locations
πŸ‡ΊπŸ‡Έ

Memorial Sloan Kettering Cancer Center, New York, New York, United States

Β© Copyright 2025. All Rights Reserved by MedPath